These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 33410)

  • 1. Neuroleptic CNS effects: acute and chronic studies.
    Bunney BS
    Psychopharmacol Bull; 1979 Jan; 15(1):57-8. PubMed ID: 33410
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine-sensitive adenylate cyclase and receptor binding activities after acute and chronic neuroleptic drug treatment.
    Clement-Cormier Y
    Adv Biochem Psychopharmacol; 1980; 24():103-11. PubMed ID: 6105768
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical and behavioral studies of D1 dopamine receptors utilizing SCH 23390.
    Hess EJ; Creese I
    Psychopharmacol Bull; 1986; 22(3):605-12. PubMed ID: 2879304
    [No Abstract]   [Full Text] [Related]  

  • 4. Site-specific blockade of dopamine receptors by neuroleptic agents in human brain.
    Borison RL; Fields JZ; Diamond BI
    Neuropharmacology; 1981 Dec; 20(12B):1321-2. PubMed ID: 6119643
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of neuroleptic drugs on endogenous opioid peptides in the rat.
    Höllt V
    Mod Probl Pharmacopsychiatry; 1981; 17():1-18. PubMed ID: 6120450
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of long-term neuroleptic administration on CNS receptors plasticity].
    Allikmets LKh; Zharkovskiĭ AM; Nurk AM; Vasar EE; Maĭmets MO
    Vestn Akad Med Nauk SSSR; 1984; (11):37-42. PubMed ID: 6152099
    [No Abstract]   [Full Text] [Related]  

  • 7. Adaptive changes in brain dopamine function as a result of neuroleptic treatment.
    Jenner P; Marsden CD
    Adv Neurol; 1988; 49():417-31. PubMed ID: 2894127
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroleptic drugs and their action on different neuronal pathways.
    Ungerstedt U; Herrera-Marschitz M; Forster C
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):34-7. PubMed ID: 2858478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
    Bacopoulos NG
    J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic neuroleptic treatment and dopamine receptor regulation.
    Creese I; Snyder SH
    Adv Biochem Psychopharmacol; 1980; 24():89-94. PubMed ID: 6105809
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dopaminergic receptors, multiple targets for neuroleptics].
    Martres MP; Sokoloff P; Giros B; Bouthenet ML; Pilon C; Lannfelt L; Schwartz JC
    Ann Med Psychol (Paris); 1992; 150(2-3):119-23. PubMed ID: 1364189
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple forms of the D1 dopamine receptor: its linkage to adenylate cyclase and psychopharmacological effects.
    Mailman RB; Schulz DW; Kilts CD; Lewis MH; Rollema H; Wyrick S
    Psychopharmacol Bull; 1986; 22(3):593-8. PubMed ID: 2879302
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in the sensitivity of brain dopamine and serotonin receptors during the prolonged administration of carbidine].
    Zharkovskiĭ AM; Chereshka KS; Zharkovskaia TA; Allikmets LKh
    Biull Eksp Biol Med; 1985 Dec; 100(12):719-22. PubMed ID: 2866801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of neuroleptics with central dopamine and noradrenaline receptor blocking properties in the L-DOPA and (+)-amphetamine-induced waking EEG in the rat.
    Monti JM
    Br J Pharmacol; 1979 Sep; 67(1):87-91. PubMed ID: 40644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The window of vulnerability in the ontogeny of the dopamine receptor.
    Miller JC; Friedhoff AJ
    Psychopharmacol Bull; 1985; 21(3):683-5. PubMed ID: 2863851
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of chronic administration of neuroleptic and anticholinergic agents on densities of D2 dopamine and muscarinic cholinergic receptors in rat striatum.
    Boyson SJ; McGonigle P; Luthin GR; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1988 Mar; 244(3):987-93. PubMed ID: 2908050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug effects on pre- and postsynaptic dopamine receptors.
    Andén NE; Grabowska-Andén M
    Adv Biochem Psychopharmacol; 1980; 24():57-64. PubMed ID: 6105802
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current status of our knowledge of the neurotropic side effects of neuroleptic drugs].
    Sabbatini F; Pinessi L; Gentile S; De Mattei M; Portaleone P
    Minerva Psichiatr; 1983; 24(4):145-53. PubMed ID: 6145083
    [No Abstract]   [Full Text] [Related]  

  • 19. Brain dopamine receptors.
    Seeman P
    Pharmacol Rev; 1980 Sep; 32(3):229-313. PubMed ID: 6117090
    [No Abstract]   [Full Text] [Related]  

  • 20. The possible role of dopamine autoreceptors in neuroleptic atypicality.
    Javitt DC; Weinstein SL; Opler LA
    Psychiatr Dev; 1988; 6(1):57-71. PubMed ID: 2902622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.